Across TCGA pan-cancer cohorts, RPL35AP30 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL35AP30’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL35AP30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL35AP30 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD and KICH are the cancer types where RPL35AP30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL35AP30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.146	.032	4	view →
KICH	All	All	−0.064	.011	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL35AP30 RNA expression & survival · all RPL35AP30 data types